期刊文献+

我院1998~2002年临床分离菌耐药性现状及合理使用抗生素 被引量:11

Present status of antibiotic resistance of clinical isolates from 1998 to 2002 and the rational use of antibiotics
暂未订购
导出
摘要 目的对1998~2002年临床分离致病菌药敏结果做综合分析,为临床合理使用抗生素提供科学依据。方法主要使用VITEK-32全自动微生物分析仪对1998年1月~2002年12月全院患者送检培养呈阳性的标本进行细菌鉴定和药敏试验,少数标本的抗生素敏感性测定采用K-B纸片法。结果5年间常见细菌对各种抗生素的耐药性都不同程度增强,革兰氏阴性杆菌对亚胺培南最敏感,革兰氏阳性球菌对万古霉素最敏感。耐甲氧西林葡萄球菌和产ESBLs细菌都有逐年增加的趋势。结论细菌的耐药性越来越强,多重耐药菌也越来越多,我们应重视医院感染,加强耐药检测,合理使用抗生素。 Objective To analyze the surveillant results of antibiotics suscep tibility of clinical isolates, and to guide the appropriate use of antibiotics.M ethods The strains isolated from patients during 1997 to the end of 2001 were id entified and drug sensitive tests were performed using automated microbial analy sis system VITEK-32 and K-B methods.Results The antibiotics resistance rates increased during this five years.Imipenem was most sensitive for Gram-negativ e rods,and vancomycin was most sensitive for Gram-positive cocci.While the eme rgence of methicillin resistant staphylococci(MRS) and ESBL producing bacteria i ncreased year after year.Conclusion Confronted with the rapid emergency of nosoc omial multidrug resistant strains presents significant therapeutica challenges a nd therefore,the rational use of antibiotic therapy based on susceptibility test s should be emphasizes.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2003年第12期718-722,共5页 Chinese Journal of Antibiotics
关键词 病原菌 医院感染 耐药性 抗生素 细菌鉴定 药敏试验 Pathogen Nosocomial infection Antibiotic resistance Anti biotics
  • 相关文献

参考文献6

  • 1[1]Mendes C,Hsiung A,Kiffor C,et al.Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil:MYSTIC Antimicrobial Surveillance Program [J].Braz J Infect Dis, 2000, 4(5):236
  • 2[2]Stoward C D,Wallaoo D,Hubort S K,et al.Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE Laboratories [J].Diagn Microbiol Infect Dis, 2000, 38(1):59
  • 3[3]Wu T L,Siu L K,Su L H,et al.Outer membrane protein change combined with CO- existing TEM- 1 and SHV- 1 beta- lactamases lead to false identification of ESBL- producing Klebsiella pneumoniae [J].J Antimicrob Chemother, 2001, 47(16):755
  • 4[4]Pfaller M A,Acar J,Jones R N,et al.Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program[J].Clin Infect Dis, 2001, 32(Suppl 2):156
  • 5[5]Lzutenbach E,Patel J B,Bilker W B,et al.Extended- spectrum beta- lactamase- producing Escherichia coli and Klebsiella pneumoniae:risk factors for infection and impact of resistance on outcomes[J].Clin Infect Dis, 2001,32(8):1162
  • 6[6]Oplustil C P,Nunes R,Mendes C.Multicenter evaluation of resistance patterns of Klebsiella pneumoniae,Escherichia coli,Salmonella spp and Shigella spp isolated from clinical specimens in Brazil:RESISTNET surv eillance program [J].Braz J Infect Dis, 2001,5(1):8

同被引文献86

引证文献11

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部